Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Here’s how COVID-19 vaccine BNT162b1 produces human antibody and helper T-cell responses

Hong Kong PhD Fellowship Scheme (HKPFS) 2021-2022

Pet bearded dragons droppings cause Salmonella outbreak: Question is are they safe?

Here’s how COVID-19 vaccine BNT162b1 produces human antibody and helper T-cell responses
  • BiotechToday
  • India
  • World

Here’s how COVID-19 vaccine BNT162b1 produces human antibody and helper T-cell responses

bioxone October 4, 2020October 4, 2020

Ayooshi Mitra, Amity University Kolkata

To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified messenger RNA (mRNA) encoding the SARS-CoV-2 spike protein1 receptor-binding domain (RBD) was accounted for. Here, antibody and T-cell responses following BNT162b1 vaccination in a second, non-randomized, Phase 1/2 open-label trial in healthy adults aged 18-55 years were presented. 

Two dosages of 1 to 50 μg of BNT162b1 brought strong CD4 + and CD8 + T-cell and antibody responses, with RBD-binding IgG concentrations clearly above those in the COVID-19 sample (HCS) panel. For the 43rd day of SARS-CoV-2 serum neutralizing, mean values were 0.7-fold (1 μg) to 3.5-fold (50 μg) of the HCS panel. Immune sera broadly neutralized pseudoviruses with various SARS-CoV-2 spike variants. Most participants had positive T cell immune responses with CD8 + RBD-specific and CD4 + T-cell development. The tough RBD-specific antibody, T-cell, and favourable cytokine reactions induced by the BNT162b1 mRNA vaccine suggest multiple advantageous mechanisms with the potential to defend against the COVID-19.

References: Sahin, U., Muik, A., Derhovanessian, E. et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses. Nature (2020). https://doi.org/10.1038/s41586-020-2814-7 https://www.nature.com/articles/s41586-020-2814-7

Also read: Can high systemic inflammation biomarkers during puberty result in breast cancer?

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Antibody CORONAVIRUS COVID-19 cytokine reactions mRNA mRNA vaccine pandemic receptor binding SARS-CoV-2 successful vaccine T-cell and B-cell T-cell response VACCINE

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • India
  • World

Pet bearded dragons droppings cause Salmonella outbreak: Question is are they safe?

bioxone October 4, 2020

Prama Ghosh, Amity University Kolkata 13 people from 8 states have been infected with the outbreak strain of Salmonella muenster linked to bearded dragons, as of 25th September, according to the latest information released from the Centers for Disease Control and Prevention (CDC).  Pet bearded dragons are likely the source of this outbreak as shown […]

Salmonella

Related Post

  • BiotechToday
  • India

The potentiality of Honey in The Treatment of Diabetes Mellitus?

bioxone October 15, 2020October 15, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA “Honey” is most commonly used in Supportive and Substitute Medicine mainly in the Indian Ayurvedic Medicine since ancient times, as an additive in the treatment of Diabetes Mellitus. But in recent times the use of honey gained effective potential for the treatment of diabetes because of the increase in the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Allosteric Mechanism in CRISPR–Cas 9

bioxone November 16, 2020November 15, 2020

Anannya Roy, Amity University Kolkata CRISPR stands for clustered regularly interspaced short palindromic repeats. Quite a mouthful isn’t it? In the name itself is hidden, its definition. It is composed of short identical palindromic DNA segments that are separated with spacer DNA, which are all unique. There are also a number of genes associated with […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Parenteral Nutrition for treating ovarian cancer

bioxone July 13, 2021July 12, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Ovarian cancer causes a higher mortality rate in women, as compared to other gynaecological cancers. It is characterized by a late presentation and the absence of obvious symptoms. The late diagnosis of ovarian cancer leads to reduced calorie intake and eventually malnutrition. Malnutrition is presumed to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy